Search research articles
Contact Us
Filters
Showing results (561-570 of 595) with videos related to
Page
of 60
Sort By:
Central Nervous System Agents in Medicinal Chemistry
|
August 31, 2012
Synthesis and pharmacological evaluation of novel 4-alkyl-5-thien-2'-yl pyrazole carboxamides
Paolo Lazzari, Amedeo Pau, Simone Tambaro, et al.
European Journal of Medicinal Chemistry
|
February 19, 2016
Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties
Valeria Deiana, María Gómez-Cañas, M Ruth Pazos, et al.
European Journal of Medicinal Chemistry
|
July 13, 2019
Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors
Gabriele Murineddu, Cecilia Gotti, Battistina Asproni, et al.
The Biochemical Journal
|
June 21, 2003
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)
Stefania Sarno, Erika de Moliner, Maria Ruzzene, et al.
European Journal of Medicinal Chemistry
|
January 15, 2017
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
Giulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Biochemistry
|
June 9, 2005
Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity
Arianna Donella-Deana, Oriano Marin, Luca Cesaro, et al.
The American Journal of Gastroenterology
|
July 1, 1998
Thyroid and celiac disease: clinical, serological, and echographic study
F Velluzzi, A Caradonna, M F Boy, et al.
Chemmedchem
|
May 1, 2015
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors
Amedeo Pau, Marco Catto, Giovanni Pinna, et al.
Biochemistry
|
August 30, 2011
Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer
Roberto Battistutta, Giorgio Cozza, Fabrice Pierre, et al.
Bone Marrow Transplantation
|
July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial
D Valteau-Couanet, C Faucher, A Aupérin, et al.
Page
of 60
Search research articles
Search
Showing results (561-570 of 595) with videos related to
Sort By:
Page
of 60
Central Nervous System Agents in Medicinal Chemistry
|
August 31, 2012
Synthesis and pharmacological evaluation of novel 4-alkyl-5-thien-2'-yl pyrazole carboxamides
Paolo Lazzari, Amedeo Pau, Simone Tambaro, et al.
European Journal of Medicinal Chemistry
|
February 19, 2016
Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties
Valeria Deiana, María Gómez-Cañas, M Ruth Pazos, et al.
European Journal of Medicinal Chemistry
|
July 13, 2019
Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors
Gabriele Murineddu, Cecilia Gotti, Battistina Asproni, et al.
The Biochemical Journal
|
June 21, 2003
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)
Stefania Sarno, Erika de Moliner, Maria Ruzzene, et al.
European Journal of Medicinal Chemistry
|
January 15, 2017
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
Giulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Biochemistry
|
June 9, 2005
Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity
Arianna Donella-Deana, Oriano Marin, Luca Cesaro, et al.
The American Journal of Gastroenterology
|
July 1, 1998
Thyroid and celiac disease: clinical, serological, and echographic study
F Velluzzi, A Caradonna, M F Boy, et al.
Chemmedchem
|
May 1, 2015
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors
Amedeo Pau, Marco Catto, Giovanni Pinna, et al.
Biochemistry
|
August 30, 2011
Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer
Roberto Battistutta, Giorgio Cozza, Fabrice Pierre, et al.
Bone Marrow Transplantation
|
July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial
D Valteau-Couanet, C Faucher, A Aupérin, et al.
Page
of 60